Table V.
Parameter | Hazard ratio (95% confidence interval) |
P value |
---|---|---|
At Complete Remission (N=260) | ||
| ||
Age | 1.006 (0.992, 1.021) | 0.39 |
WBC | 1.005 (1.003, 1.006) | <0.0001 |
Cytogenetics | 0.815 (0.498, 1.333) | 0.41 |
MRD at CR | 2.263 (1.432, 3.576) | 0.0005 |
| ||
At 3 Months from Therapy Initiation (N=216) | ||
| ||
Age | 1.003 (0.989, 1.018) | 0.67 |
WBC | 1.004 (1.003, 1.006) | <0.0001 |
Cytogenetics | 0.925 (0.570, 1.503) | 0.75 |
MRD at 3 Months | 1.976 (0.790, 4.944) | 0.145 |
| ||
At 6 Months from Therapy Initiation (N=166) | ||
| ||
Age | 1.001 (0.987, 1.016) | 0.86 |
WBC | 1.004 (1.002, 1.006) | <0.0001 |
Cytogenetics | 1.059 (0.653, 1.715) | 0.82 |
MRD at 6 Months | 3.969 (1.214, 12.691) | 0.02 |
WBC, white blood cell count; MRD, minimal residual disease; CR, complete remission